From NANOmedicine to nanoMEDICINE: Converging Innovation for Clinical Adoption

ABOUT THE EVENT

A national milestone for nanomedicine in Italy

“From NANOmedicine to nanoMEDICINE: Converging Innovation for Clinical Adoption” is the first official symposium of the Italian Nanomedicine Platform, a new national initiative designed to connect technological innovation, clinical expertise, and industrial engagement around shared health priorities.

Over three days in Rome, the event will bring together researchers, clinicians, institutions, and industry to co-design the future of nanomedicine in Italy, with rare diseases and oncology as key model areas.

The symposium is co-organized with:

• ETPN – European Technology Platform on Nanomedicine
• MetabERN – European Reference Network for Hereditary Metabolic Disorders 
  
  

REGISTRATION & PAYMENT

1. Registration (required)
   Before making any payment, please complete the registration.

2. Payment (after registration)
   Once you have registered, please proceed with the payment using one (or both) of the following links (after the registration):

• Participation Fee (mandatory)

  • Standard fee (€ 60): closed
  • Late fee (€ 100): closed
    
    

• Social Dinner (optional)

  • Standard rate (€ 50): closed
  • Late rate (€ 75): closed
    
    The social dinner will take place on 17 February at 20:30 at Miraggio, a typical Roman restaurant, in Trastevere (Via della Lungara 16/A, Rome) - opposite the Accademia dei Lincei (Villa Farnesina) and a very short walk from the historic Regina Coeli prison: the perfect Roman irony, where refinement and correction keep each other company.
    
    

BANK TRANSFER
As an alternative to online payment, fees may also be settled via bank transfer. 
Please indicate the participant’s full name and the type of fee (Standard/Late Participation Fee and/or Social Dinner) in the payment reference.

Bank Details:
Beneficiary: Associazione NanoItaly APS
IBAN: IT59A0200805227000107312990
Bank: Unicredit S.p.A.

DEADLINES

• Pitch abstract submission deadline: closed

• Registration and payment deadline: 15 February 2026

LOCATION

Sapienza University of Rome
Main Campus
Building CU 014
P.le A. Moro, 5

OBJECTIVES

What we aim to achieve

This high-level symposium is designed to:

• Officially launch the Italian Nanomedicine Platform and its Working Groups.
• Build shared strategic priorities among clinicians, researchers, institutions, and companies.
• Co-create and launch the first White Paper on Nanomedicine in Italy, with publication planned within 60 days after the event.
• Promote institutional and political engagement, including collaboration with Farmindustria as strategic partner.
• Test a new event format that favours dialogue, co-design, and real collaboration over traditional one-way presentations.
• Empower a new generation of researchers able to bridge lab, clinic, and industry.

DRAFT PROGRAMME AT A GLANCE

Day 1 – Monday, 16 February 2026 (Afternoon)
Kick-off & Platform Launch - Registration will open at 13:00

14:00 - 14:30
Institutional opening and welcome hosted by Alessandra Gentile, Deputy Head of the Department of Chemistry, Sapienza University of Rome

Maria Sabrina Sarto, Pro-Rector for Research, Sapienza University of Rome
Livia Ottolenghi, Deputy Dean of the Faculty of Medicine and Dentistry, Sapienza University of Rome
Marco Salvetti, Deputy Dean of the Faculty of Medicine and Psychology, Sapienza University of Rome
Luciano De Sio, Delegate of the Dean of the Faculty of Pharmacy and Medicine: Prof. Paolo Villari, Sapienza University of Rome
Laurent Lévy, Chairman of ETPN, CEO of Nanobiotix
Alexandre Ceccaldi, General Secretary of the ETPN
Enrico Piccinini, Coordinator of the National Working Group on Rare Diseases Farmindustria
Maria Paola Trotta, Head of Innovation and Scientific Advice Office, AIFA
Giovanni Tosi, NanoItaly Association, Coordinator of the Italian Nanomedicine Platform, Unimore

14:30 - 15:00  
Presentation of Platform governance: Vision, and Working Groups

15:00 - 15:30
Working Groups: Presentation and Alignment on prioritie

----- Coffee Break - Networking boards: “1-1-1 Wall” + Jobs board -----

16:00 - 18:00
Pitch Session: 3-minute pitches from labs, hospitals, and companies (who we are, what we bring, what we need)

Day 2 – Tuesday, 17 February 2026 (Full day)
From Research to Reliable Products – From Clinic to Health Impact

09:00 - 12:30 – Keynotes & Reverse Pitches

09:00 - 09:30
Keynote 1
Diego Ardigò (CV), Chiesi Farmaceutici S.p.A., Parma:
PLUTO project in rare diseases (ABS)

09:30 - 10:00
Keynote 2
Raymond Schiffelers (CV), Univ. Medical Center Utrecht, The Netherlands:
mRNA-LNP and in vivo CAR-T for next-generation cancer immunotherapy (ABS)

10:00 - 10:30
Keynote 3
Dr. Alexandre Ceccaldi, General Secretary of the European Technology Platform on Nanomedicine
European Environment: The European Technology Platform for Nanomedicine

----- Coffee Break -----

11:00 - 11:30
Clinician Reverse Pitch - Maurizio Scarpa (CV), Coordinator of MetabERN & Univ. of Padua:
What Hospitals Really Need to use/Develop Nanomedicine, a European Perspective (ABS)

11:30 - 12:00
Industry Reverse Pitch - Laurent Lévy (CV), Chairman of ETPN, CEO of Nanobiotix, France: 
Selecting Nanomedicine Projects That Reach Patients: An Industrial Perspective on Clinical Fit, Differentiation, and Scalability

12:00 - 12:30 
Outputs: Clinician Go-Guide and Industry Go-Guide for the White Paper

----- Lunch Break -----

14:30 - 18:00 – Parallel Roundtables 
Each participant will choose one of the two roundtables to attend

• RoundTable 1 - Product/Translation – From Research to Reliable Products

  • Translating innovation: from concept to product definition
  • Scaling up smart: manufacturing, GMP, CMC, and industrial translation
    
    

• RoundTable 2 – Clinic/Adoption – From Clinic to Health Impact

  • Clinical readiness in rare diseases
  • Evidence for adoption in oncology

Each table will deliver 3 key priorities for the White Paper.

     ----- Coffee Break 16:00 - 16:30 -----

Evening - Social Dinner at 20:30 at Miraggio (Via della Lungara 16/A, Rome)
(To download the full menu click HERE)

Day 3 – Wednesday, 18 February 2026 (Morning)
Shaping the Future Together

09:00 - 09:45
Reports from focus groups (Top-3 priorities/actions per table)

09:45 - 10:30
Live ranking to select the Top-5 Actions for 2026

----- Coffee Break -----

11:00 - 11:30
Plan and timeline for the Italian Nanomedicine White Paper

11:30 - 12:30
Platform governance and next steps, including a Q2 2026 “Rome Review” webinar

12:30 - 13:00
Closing remarks and European perspective

AUTHORITIES & PATRONAGES

Institutional authorities and stakeholders

Key national stakeholders invited to participate include:

• Ministry of Health
• AIFA – Italian Medicines Agency, Dr.ssa Maria Paola Trotta, Innovazione e Scientific Advice e Dr.ssa Eleonora Agricola, Innovation Office and Scientific Advice EMA 
• Farmindustria, Dr. Enrico Piccinini, Rare Diseases Group Coordinator

Patronages (confirmed and invited)

• SITELF – Italian Society of Pharmaceutical Technologists
• MetabERN – European Reference Network for Hereditary Metabolic Disorders
• Farmindustria
• Patronages under invitation/confirmation: EVITA, CN3 PNRR

WHO SHOULD ATTEND

This symposium is aimed at:

• Researchers and PIs in nanomedicine, drug delivery, biomaterials, and advanced therapies
• Clinicians and healthcare professionals interested in nanotechnology-based solutions
• Representatives of pharmaceutical and biotech companies, SMEs, start-ups
• Regulatory and policy experts (AIFA, EMA, ministries, agencies)
• Patient representatives and networks, particularly in rare diseases and oncology
• Early-career researchers, PhD candidates, and postdocs interested in translational paths